Cargando…
Remarkable Improvement in a Patient with Idiopathic Pulmonary Fibrosis after Treatment with Nintedanib
Nintedanib has been shown to significantly reduce the annual rate of decline in the forced vital capacity (FVC) in patients with idiopathic pulmonary fibrosis (IPF) in previous randomized trials. A 71-year-old man developed exertional dyspnea and was diagnosed with IPF. Four months after treatment w...
Autores principales: | Nakano, Akiko, Ohkubo, Hirotsugu, Fukumitsu, Kensuke, Fukuda, Satoshi, Kanemitsu, Yoshihiro, Takemura, Masaya, Maeno, Ken, Ito, Yutaka, Oguri, Tetsuya, Niimi, Akio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522408/ https://www.ncbi.nlm.nih.gov/pubmed/30568147 http://dx.doi.org/10.2169/internalmedicine.1890-18 |
Ejemplares similares
-
Aortoesophageal Fistula Occurring during Lung Cancer Treatment: A Case Treated by Thoracic Endovascular Aortic Repair
por: Ito, Keima, et al.
Publicado: (2019) -
A case of non-small cell lung cancer with long-term response after re-challenge with nivolumab
por: Ito, Keima, et al.
Publicado: (2019) -
Frequency and impact on clinical outcomes of sarcopenia in patients with idiopathic pulmonary fibrosis
por: Fujita, Kohei, et al.
Publicado: (2022) -
Genetic variation in the ATP binding cassette transporter ABCC10 is associated with neutropenia for docetaxel in Japanese lung cancer patients cohort
por: Sone, Kazuki, et al.
Publicado: (2019) -
Acute Eosinophilic Pneumonia Induced by Switching from Conventional Cigarette Smoking to Heated Tobacco Product Smoking
por: Tajiri, Tomoko, et al.
Publicado: (2020)